Indeed, when we only affect SEMA3A expression in tumor cells (via overexpression or deletion), tumor growth was not affected, consistent with the hypothesis that atttenuation of Treg’s is needed to fully release CD8+ effector T cells. The gene discussed is CD8A; the disease is neoplasm.